Speeding Up Antibody Discovery for Infectious Disease

Discover how High Throughput Gene Synthesis from Twist is being used to develop candidate antibody therapies in under 60 days.

Tasked with an ambitious goal from DARPA to develop a rapid response to help medical workers fight viral diseases in the field, Vanderbilt University Medical Center has already reduced the time to develop antibodies significantly. High-throughput, synthetic genes from Twist Bioscience have allowed the lab to expedite this process.


Covered in this Case Study
A breakdown of DARPAs pandemic prevention platform from Vanderbilt University Medical Center.
The challenges of rapid antibody discovery.
How the scale of Twists Gene Synthesis enables a dramatically accelerated antibody discovery pipeline.
Share your details to Get the Case Study